Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
CardioNerds @AHA23: ORBITA-2: PCI for Stable Angina
Author(s): Rasha Al-Lamee , Christopher Rajkumar , Nazli Okumus Added: 5 months ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA… View more

Intervention
Author(s): Gregg Stone Added: 6 years ago
In this video, Dr Gregg Stone discusses 'what is the biggest weakness of ORBITA?'. View more

Intervention
Author(s): Matthew Jackson , Azfar Zaman Added: 3 years ago
Medical therapy has been the primary treatment for stable angina since nitroglycerin was first used in 1878. However, since the first successful percutaneous coronary intervention (PCI) procedure was performed in 1977, the role of PCI in patients with stable coronary artery disease (CAD) has been the subject of much study. Numerous trials have shown no reduction in death or myocardial infarction… View more

Prevention & Chronic Conditions
Author(s): Gregg Stone Added: 6 years ago
In this video, Dr Gregg Stone answers; 'Why Do You Think That Orbita Failed to Show a Significant Improvement in Exercise Capacity Post PCI?' View more

Intervention
AHA 2023 CardioNerds Conference Scholars Late-Breaking Video Collection
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 5 months ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs. View more

Vascular Disease and Surgery

Heart Failure
Parallax: The Year 2023 in Review with Dr Sukh Nijjer
Author(s): Ankur Kalra , Sukhjinder Nijjer Added: 4 months ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their… View more

Anticoagulation

Standards & Guidelines
View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 6 days ago
Unpack ACC.24's Top Trials with View from the Thoraxcenter!Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.In this thought-provoking ACC 2024 wrap-up, delve into the nuances of the most impactful trials, gaining insights into their implications for current practice and future research directions.00:29 -… View more

Standards & Guidelines

Heart Failure
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
2017 and all that. The 2017 ESC/EACTS Guidelines for the management of valvular heart disease1 and in particular the recommendations with regard to choice of intervention mode for the treatment of aortic stenosis, may effect more change in cardiology treatment algorithms than most original research published in 2017, marking as they do, a significant shift towards transcatheter aortic valve… View more

Intervention
AHA 23: 3 Trials That Will Change My Practice
Author(s): Dipti Itchhaporia Added: 4 months ago
AHA 23 - Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute, US), interventional cardiologist and Past President of the American College of Cardiology (ACC) highlights the top three late-breaking science trials from the 2023 AHA Scientific Sessions with the potential to change medical practices.Trials discussed in detail include:SELECT: Semaglutide and Cardiovascular Outcomes in Obesity… View more

Anticoagulation

Standards & Guidelines
ACC.24: Late-Breaking Science Video Collection
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 week ago
Our recurring review series, View from the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offers a thorough examination of late-breaking and featured scientific findings, highlighting significant data.To delve deeper into the pivotal clinical trial data unveiled at ACC 24, Dr Harriette Van Spall (McMaster University, Hamilton, CA)… View more

Heart Failure

MI/ACS